Related Experiment Video

Updated: Aug 29, 2026

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination
12:33

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

Published on: June 25, 2014

Uncoupling protein 2 and islet function

Catherine B Chan1, Monique C Saleh, Vasilij Koshkin

  • 1Department of Biomedical Sciences, University of Prince Edward Island, Charlottetown, Prince Edward, Canada. cchan@upei.ca

Diabetes
|January 30, 2004
PubMed

Insights

Uncoupling protein 2 (UCP2) negatively impacts insulin secretion and beta-cell function in type 2 diabetes. UCP2 knockout mice show improved beta-cell mass and insulin secretion under glucolipotoxic conditions.

Area of Science:

  • Endocrinology
  • Metabolic disease research
  • Molecular biology

Background:

  • Chronic hyperglycemia and hyperlipidemia are key contributors to type 2 diabetes.
  • The molecular mechanisms underlying impaired insulin secretion are under investigation.
  • Uncoupling protein 2 (UCP2) is implicated as a negative regulator of insulin secretion.

Purpose of the Study:

  • To investigate the role of UCP2 in mediating the effects of glucolipotoxicity on beta-cell function.
  • To explore the impact of UCP2 modulation on insulin secretion and beta-cell mass.

Main Methods:

  • Analysis of UCP2 expression in beta-cells under glucolipotoxic conditions.
  • Assessment of insulin secretion in the presence of altered UCP2 activity.
  • Evaluation of beta-cell mass and function in UCP2 knockout mice exposed to glucolipotoxicity.

Main Results:

  • Beta-cell UCP2 expression is upregulated by glucolipotoxic conditions.
  • Increased UCP2 activity is associated with decreased insulin secretion.
  • UCP2 knockout mice exhibit increased beta-cell mass and preserved insulin secretion capacity when challenged with glucolipotoxicity.

Conclusions:

  • UCP2 plays a detrimental role in insulin secretion and beta-cell function under glucolipotoxic conditions, despite potential protective effects.
  • Targeting UCP2 may represent a therapeutic strategy for type 2 diabetes by preserving beta-cell function and mass.

More Related Videos

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets10:09

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

Analysis of Beta-cell Function Using Single-cell Resolution Calcium Imaging in Zebrafish Islets08:50

Analysis of Beta-cell Function Using Single-cell Resolution Calcium Imaging in Zebrafish Islets

Published on: July 3, 2018

Related Concept Videos

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...